Ginkgo Bioworks Holdings Inc vs First Citizens BancShares Inc — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.27 (market cap $485.52M), while First Citizens BancShares Inc trades at $2,270.44 (market cap $25.26B). The key difference: First Citizens BancShares Inc is far larger — about 52× Ginkgo Bioworks Holdings Inc's market cap, and First Citizens BancShares Inc pays a 0.37% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.
| DNA | FCNCA | |
|---|---|---|
Market Cap | $485.52M | $25.26B |
Sector | Health | Sector/Thematic |
52-Week High | $16.14 | $2.27K |
52-Week Low | $5.48 | $1.64K |
Enterprise Value | $587.47M | — |
Dividend Yield | — | 0.37% |
Trailing returns across standard periods
Latest headlines on both assets
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →First Citizens BancShares is a major US regional bank providing diverse financial services. It recently expanded significantly by acquiring the assets and liabilities of Silicon Valley Bank.
Read more on FCNCA →